International
The Morning Science

What science found today

‹
 

Topic

Mash

3 stories about Mash that passed the news check, newest first.

  1. Research ·

    TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling

    A study in Science Advances reports that TLR5 drives metabolic dysfunction-associated steatohepatitis (MASH).

    science.org

  2. Research ·

    Selective mTOR inhibition via FLCN drives TFE3-dependent VLDL-TG secretion and protects from MAFLD/MASH

    A Nature Communications study reports a pathway in which selective, non-canonical mTOR signaling via FLCN regulates VLDL assembly and secretion.

    nature.com

  3. Research ·

    Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement

    In patients treated with resmetirom (Rezdiffra), early responses in blood and imaging biomarkers were associated with resolution of MASH.

    MedPageToday.com - medical news for physicians